Literature DB >> 6240373

Dermatitis due to transdermal therapeutic systems.

A A Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6240373

Source DB:  PubMed          Journal:  Cutis        ISSN： 0011-4162


× No keyword cloud information.
  5 in total

1.  Percutaneous absorption enhancement of leuprolide.

Authors:  M Y Lu; D Lee; G S Rao
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

2.  Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.

Authors:  Jeffrey L Cummings; Martin R Farlow; Xiangyi Meng; Sibel Tekin; Jason T Olin
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 3.  Skin sensitivity and transdermal drug delivery. A review of the problem.

Authors:  A J Carmichael
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 4.  Contact dermatitis due to transdermal therapeutic systems: a clinical update.

Authors:  Paolo Romita; Caterina Foti; Gianfranco Calogiuri; Stefania Cantore; Andrea Ballini; Gianna Dipalma; Francesco Inchingolo
Journal:  Acta Biomed       Date:  2018-10-26

5.  Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures.

Authors:  T Iannitti; V Rottigni; B Palmieri
Journal:  Drug Des Devel Ther       Date:  2013-09-26       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.